MCT powder ( DrugBank: - )


1 disease
IDDisease name (Link within this page)Number of trials
296Biliary atresia1

296. Biliary atresia


Clinical trials : 63 Drugs : 65 - (DrugBank : 37) / Drug target genes : 45 - Drug target pathways : 63
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05072626
(ClinicalTrials.gov)
October 11, 202113/9/2021High Medium-chain Triglyceride Nutritional Support in Infants With Biliary AtresiaStudy on High Medium-chain Triglyceride Nutritional Support in Infants With Biliary Atresia After Kasai PortoenterostomyBiliary Atresia;Infant;Nutrition Support;Medium-chain TriglycerideCombination Product: high MCT formula;Dietary Supplement: MCT powderChildren's Hospital of Fudan UniversityNULLRecruitingN/A3 MonthsAll300N/AChina